Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on August 25, 2025
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
GlobeNewswire
·
August 25, 2025
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, where new …
Smarter, Faster, and More Human: Cerence AI and Volkswagen Advance Partnership to Deliver Next-Gen In-Car Conversations
GlobeNewswire
·
August 25, 2025
BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced the next evolution of its successful collaboration with the Volkswagen …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
GlobeNewswire
·
August 25, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 25, 2025
AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, such as Tuberous …
Locafy to Present at the 2025 Gateway Conference on September 3rd
GlobeNewswire
·
August 25, 2025
PERTH, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company specializing in ”entity-based” search engine optimization (SEO), will …
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Byrna Reports 50% Surge in Average Daily Web Visits Following Launch of New AI Advertising Process
GlobeNewswire
·
August 25, 2025
Byrna.com Sessions Averaged More than 50,000 per Day During First 21 Days of August, the Highest Level in Company History Byrna’s “We Don’t Sell Bananas” AI-Created Commercial Surpasses 66 Million Views ANDOVER, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- …
4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib
GlobeNewswire
·
August 25, 2025
- Immuneering to evaluate atebimetinib in combination with olomorasib in planned Phase 2 trial in patients with advanced non-small cell lung cancer – CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical- …
Bright Minds Biosciences to Present at Upcoming Conferences
GlobeNewswire
·
August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, …
Clip Money Inc. Reports Second Quarter 2025 Results
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the …
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …
CRAFTSMAN+ Achieves Spot #2476 on the 2025 Inc. 5000 List With 171% Revenue Growth
GlobeNewswire
·
August 25, 2025
New York, NY, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Inc. has named CRAFTSMAN+ No. 2476 on its 2025 Inc. 5000 list, recognizing the fastest-growing private companies in the U.S. The list celebrates dynamic, independent businesses that are shaping the economy— …
UPCX Signs MOU with Paycle and NTT Digital to Advance Next-Generation Decentralized Payment System
GlobeNewswire
·
August 25, 2025
Singapore, Aug. 25, 2025 (GLOBE NEWSWIRE) -- UPCX proudly announces the signing of a Memorandum of Understanding (MOU) with Paycle Inc. (“Paycle”) and NTT Digital, Inc. (“NTT Digital”) to jointly promote research and application of a next-generation …
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
FLORHAM PARK, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of …
Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
GlobeNewswire
·
August 25, 2025
Safety and Pharmacokinetic Data Support Dosing of ART26.12 in Fed or Fasted Conditions Completion of Positive Single Ascending Dose Study with a Preliminary Food Effect Assessment Advances ART26.12 Toward Multiple Ascending Dose Trial SOLANA BEACH, Calif., …
XerpaAI Ignites WebX with the World’s First AI Growth Agent, Ushering in a New Era of Web3 Growth
GlobeNewswire
·
August 25, 2025
TOKYO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- XerpaAI made its official debut at WebX Tokyo, Asia’s largest Web3 conference, unveiling the world’s first AI Growth Agent (AGA) — an intelligent, end-to-end solution built to help emerging projects accelerate …
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
GlobeNewswire
·
August 25, 2025
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing significant unmet need Upfront cash payment of $5.35 per …
BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025
GlobeNewswire
·
August 25, 2025
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire oral presentation on …
Humanoid Global Announces CEO Transition
GlobeNewswire
·
August 25, 2025
Vancouver, BC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) announced today changes to its management. Shahab Samimi will serve as the Chief Executive Officer of the …